Asian Pharma Stocks Drop Following New Tariffs Imposed by Trump
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 26 2025
0mins
Should l Buy ?
Source: WSJ
Impact on Asian Markets: Pharmaceutical stocks in Asian markets declined following President Trump's announcement of new tariffs, particularly a 100% tariff on drugs from companies not building manufacturing plants in the U.S.
Tariff Implementation Date: The new tariff will take effect on October 1st, 2025, as stated by Trump on his social media platform, Truth Social, although specific details were not provided.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
